OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Updates in the Use of Targeted Therapies for Gynecologic Cancers
Evelyn Cantillo, Félix Blanc‐Durand, Alexandra Léary, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 3
Evelyn Cantillo, Félix Blanc‐Durand, Alexandra Léary, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 3
Showing 3 citing articles:
Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I)
Peng‐Hui Wang, Chia-Hao Liu, Szu‐Ting Yang
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 6, pp. 817-819
Open Access | Times Cited: 8
Peng‐Hui Wang, Chia-Hao Liu, Szu‐Ting Yang
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 6, pp. 817-819
Open Access | Times Cited: 8
PPP2R1A mutation status as a predictive and prognostic factor in molecularly characterized endometrial carcinoma: A cohort study
Masuma Khatun, Annukka Pasanen, Anna Kanerva, et al.
International Journal of Gynecological Cancer (2025), pp. 101934-101934
Open Access
Masuma Khatun, Annukka Pasanen, Anna Kanerva, et al.
International Journal of Gynecological Cancer (2025), pp. 101934-101934
Open Access
Genome Editing in Gynecological Oncology: The Emerging Role of CRISPR/Cas9 in Precision Cancer Therapy
Naina Kumar
Therapeutic Innovation & Regulatory Science (2025)
Closed Access
Naina Kumar
Therapeutic Innovation & Regulatory Science (2025)
Closed Access
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary
Harry E Fuentes, Pashtoon Murtaza Kasi, Li Ma, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Harry E Fuentes, Pashtoon Murtaza Kasi, Li Ma, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
